Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - ACCOUNTS PAYABLE
Accounts Payable URGN - UroGen Pharma Ltd.
6.51 M
LAST VALUE
6.10%
2 YEAR CAGR
8.80%
5 YEAR CAGR
34.59%
10 YEAR CAGR